Navigation Links
Rutgers, UMDNJ research provides unprecedented insight into fighting viral infections
Date:9/29/2011

Researchers at Rutgers and UMDNJ-Robert Wood Johnson Medical School have determined the structure of a protein that is the first line of defense in fighting viral infections including influenza, hepatitis C, West Nile, rabies, and measles.

Principal investigators of the study, "Structural basis of RNA recognition and activation by innate immune receptor RIG-I," chosen for advanced online publication in Nature, say the research is key in the development of broad-based drug therapies to combat viral infections.

"Understanding innate immunity to viral infections is crucial to developing drugs that can fight viruses or control inflammation," said Joseph Marcotrigiano, assistant professor of chemistry and chemical biology at Rutgers who along with Smita Patel, professor of biochemistry at Robert Wood Johnson Medical School, are principal investigators on the newly released study. "Having this foundation is extremely important."

RIG-I is a receptor protein that recognizes differences in molecular patterns in order to differentiate viral RNA the process during which virus particles makes new copies of themselves within a host cell and can then infect other cells -- from cellular RNA. What researchers discovered is that viral RNA, as opposed to single-stranded cellular RNA, is a double-stranded structure. This double-stranded difference is the reason the RIG-I protein recognizes it and initiates a signal to induce anti-immune and anti-inflammatory defenses within the cell.

Prior to this research, there was little information on how RIG-I protein recognized the viral infections, said Patel. "A failure of RIG-I to identify viral RNA can lead to alterations of the cell, including cell death, inflammation, autoimmune diseases, and cancer," he said.

This is a first step, the scientists say, in helping to develop therapies that interfere with a broad variety of viral infections a major breakthrough for millions of people who get sick from viral infections which cannot be treated effectively by current medication.

"This work provides unprecedented insights on the molecular mechanism of viral RNA recognition by RIG-I," said Barbara Gerratana, who oversees enzyme catalysis grants at the National Institute of General Medical Sciences of the National Institutes of Health. "As a result, we have a deeper understanding of how the human body fights viral infections a structural basis of the development of new anti-viral therapeutics."


'/>"/>

Contact: Robin Lally
rlally@ur.rutgers.edu
732-932-7084 x652
Rutgers University
Source:Eurekalert

Related biology news :

1. Rutgers, UMDNJ receive $23 million to develop antidotes for chemical weapons attacks
2. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
3. Woody biomass research grant to launch biofuel industry in the Pacific Northwest
4. Lawson research shows Canadians dont believe their eyes
5. Salk scientist receives distinguished NIH award for transformative research
6. Research solutions for sustainability in a rapidly changing world
7. Stanford Precourt Institute and TomKat Center award energy research grants
8. RIKEN OSC and Kitasato University sign joint research agreement
9. Europe punches above its weight in biomedical research, despite limited funding
10. Dead Sea researchers discover freshwater springs and numerous micro-organisms
11. Eating balanced meals, farm-fresh produce benefits families, communities, nutrition researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
Breaking Biology News(10 mins):
(Date:5/27/2016)... , ... May 27, 2016 , ... PBI-Gordon Corporation is ... and Ornamental Products. , In his 15-year career with PBI-Gordon, Dave has served in ... where he was integral in the development and launch of many of PBI-Gordon’s most ...
(Date:5/27/2016)... ISELIN, New Jersey and ... 2016 Indegene ( ... kommerziellen und marketingorientierten Lösungen für die Life-Science-Branche, ... ), ein bekannter weltweiter Anbieter von innovativen ... im Zuge des Starts von IntraScience heute ...
(Date:5/26/2016)... 2016  Agriculture nutrients are in the news these ... is running their nitrate removal system on overtime ... and coastal regions nationwide are painting the water ... issue. NECi Superior Enzymes, a biotechnology company ... a new, easy to use device that fits in ...
(Date:5/26/2016)... , May 26, 2016 Q ... that it will be a featured presenter at the 5th ... New York City at the Grand ... Corin , Q BioMed Inc. CEO, is scheduled to begin ... cover the company,s business strategy, recent developments and outline milestones ...
Breaking Biology Technology: